Please d oC hn eo mt Ca do mj u ms t margins
Page 4 of 5
COMMUNICATION
Journal Name
1
2
the surface of anode to generate radical intermediate II.
Probably, oxidation of radical intermediate II to 9 involved two
pathways. First, the intermediate II was combined with
molecular oxygen to form alkperoxide III, which underwent a
proton loss to give oxygen-centered radical IV. Next, cleavage
of the O−O bond in IV at cathode, intermediate 9 was
obtained. Second, the intermediate II was directly oxidized by
Moretto, K. Janz, M. Lowe, T. S. Mansour, C. Hubeau, K.
DOI: 10.1039/D0CC06778D
Page, P. Morgan, S. Fish, X. Xu, C. Williams and E. Saiah, J.
Med. Chem., 2014, 57, 1299−1322.
L. J. Martin, M. Koegl, G. Bader, X.-L. Cockcroft, O. Fedorov,
D. Fiegen, T. Gerstberger, M. H. Hofmann, A. F. Hohmann, D.
Kessler, S. Knapp, P. Knesl, S. Kornigg, S. Müller, H. Nar, C.
Rogers, K. Rumpel, O. Schaaf, S. Steurer, C. Tallant, C. R.
Vakoc, M. Zeeb, A. Zoephel, M. Pearson, G. Boehmelt and D.
McConnell, J. Med. Chem., 2016, 59, 4462−4475.
oxygen to form intermediate 9. Meanwhile, direct anodic
-
oxidation of I produced I
2
, which reacted with diselenide 3a to
3
4
(a) C. González-Bello, C. Abell and F. J. Leeper, J. Chem. Soc.,
Perkin Trans. 1, 1997, 1, 1017-1024; (b) J. J. Youte, D.
Barbier, A. Al-Mourabit, D. Gnecco and C. Marazano, J. Org.
Chem., 2004, 69, 2737-2740; (c) T.-T. Fan-Chiang, H.-K. Wang
and J.-C. Hsieh, Tetrahedron, 2016, 72, 5640−5645.
provide active species RSeI. Finally, RSeI was trapped by 9 to
afford the product 3a and two protons. Cathodic reduction of
proton hydrogen render to the formation of hydrogen.
Finally, we also tested the antiviral activity of selenide
isoquinolones (Table S3 and Figure S3 in the ESI). A half-leaf
method was used to determine therapeutic effect against
tobacco mosaic virus (TMV). It is gratifying to note that some
compounds had shown good antiviral activity against TMV at a
(a) Y. Jin, L. Ou, H. Yang and H. Fu, J. Am. Chem. Soc., 2017,
1
39, 14237−14243; (b) G. Wang, W. Hu, Z. Hu, Y. Zhang, W.
Yao, L. Li, Z. Fu and W. Huang, Green Chem., 2018, 20,
302−3307; (c) W.-K. Luo, X. Shi, W. Zhou and L. Yang, Org.
3
Lett., 2016, 18, 2036−2039; (d) A. Motaleb, A. Bera and P.
Maity, Org. Biomol. Chem., 2018, 16, 5081−5085; (e) D.
Wang, R. Zhang, R. Deng, S. Lin, S. Guo and Z. Yan, J. Org.
Chem., 2016, 81, 11162−11167; (f) D. Zhu, W. K. Luo, L. Yang
and D.-Y. Ma, Org. Biomol. Chem., 2017, 15, 7112−7116; (g) Z.
Fang, Y. Wang and Y. Wang, Org. Lett., 2019, 21, 434−438.
(a) Y. Yuan and A. Lei, Nature Commun., 2020, 11, 802; (b) Y.
Yuan and A. Lei, Acc. Chem. Res., 2019, 52, 12, 3309-3324;
-1
concentration of 500 μg mL . Particularly, compound 3j
showed excellent inhibition effect on TMV, and its inhibition
rate was up to 90%, which even exceeded that of the positive
control (ningnanmycin, 64.1%). Further structural optimization
and structure-activity relationship studies are in progress.
5
(c) J. C. Siu, N. Fu and S. Lin, Acc. Chem. Res., 2020, 53, 547-
5
2
60; (d) M. Yan, Y. Kawamata and P. S. Baran, Chem. Rev.,
017, 117, 13230−13319; (e) R. Francke and R. D. Little,
Conclusions
Chem. Soc. Rev., 2014, 43, 2492-2521.
In conclusion, we have disclosed an efficient and
environmentally friendly electrochemical regioselective 1,4-
difunctionalization of isoquinolinium salts with diselenides. By
this protocol, various selenide isoquinolones were accessed
under undivided electrolytic conditions. In addition, the
electrocatalytic system was successfully extended to
synthesize selenide quinolones and 1,3-dimethyl-1H-
6
7
(a) J. Yoshida, K. Kataoka, R. Horcajada and A. Nagaki, Chem.
Rev., 2008, 108, 2265−2299; (b) S. R. Waldvogel and B. Janza,
Angew. Chem. Int. Ed., 2014, 53, 7122−7123; (c) M. K.
Kärkäs, Chem. Soc. Rev., 2018, 47, 5786−5865.
(a) L. Sancineto, A. Mariotti, L. Bagnoli, F. Marini, J. Desantis,
N. Iraci, C. Santi, C. Pannecouque and O. Tabarrini, J. Med.
Chem., 2015, 58, 9601–9614; (b) G. Mugesh, W. W. du Mont
and H. Sies, Chem. Rev., 2001, 101, 2125–2180; (c) C. W.
Nogueira, G. Zeni and J. B. T. Rocha, Chem. Rev., 2004, 104,
6255–6285; (d) D. S. Rampon, F. S. Rodembusch, J. M. F. M.
Schneider, I. H. Bechtold, P. F. B. Goncalves, A. Merlo and P.
H. Schneider, J. Mater. Chem., 2010, 20, 715–722; (e) D.
Tanini, B. Lupori, G. Malevolti, M. Ambrosi, P. L. Nostro and
A. Capperucci, Chem. Commun., 2019, 55, 5705–5708; (f) A.
Angeli, D. Tanini, A. Nocentini, A. Capperucci, M. Ferraroni,
P. Gratteri and C. T. Supuran, Chem. Commun., 2019, 55,
benzo[d]imidazol-2(3H)-ones.
Importantly,
selenide
isoquinolones prepared by present method exhibited high
fluorescence absorption and emission intensity, and good
antiviral activity against tobacco mosaic virus. More in-depth
studies of biological activity are ongoing and will be reported
in near future.
6
48–651.
8
9
(a) Z. Y. Wen, J. W. Xu, Z. W. Wang, H. Qi, Q. L. Xu, Z. S. Bai,
Q. Zhang, K. Bao, Y. L. Wu and W. G. Zhang, Eur. J. Med.
Chem., 2015, 90, 184; (b) Guan, C. M. Han, D. Y. Zuo, M. A.
Zhai, Z. Q. Li, Q. Zhang, Y. P. Zhai, X. W. Jiang, K. Bao, Y. L. Wu
and W. G. Zhang, Eur. J. Med. Chem., 2014, 87, 306–315; (c)
H. R. P. Naik, H. S. B. Naik, T. R. R. Naik, H. R. Naika, K.
Gouthamchandra, R. Mahmood and B. M. Ahamed, Eur. J.
Med. Chem., 2009, 44 , 981-989.
Conflicts of interest
There are no conflicts to declare.
Acknowledgements
This work was supported by the National Natural Science
Foundation of China (22001045), Outstanding Youth Project of
Guangdong Natural Science Foundation (2020B1515020026),
the Innovation and Strong School Project of Guangdong
Pharmaceutical University (2019KQNCX061), Special funds of
key disciplines construction from Guangdong and Zhongshan
cooperating.
(a) X. Zhang, C. Wang, H. Jiang and L. Sun, Chem. Commun.,
2
018, 54, 8781–8784; (b) J. Hua, Z. Fang, J. Xu, M. Bian, C.
Liu, W. He, N. Zhu, Z. Yang and K. Guo, Green Chem., 2019,
1, 4706-4711; (c) L. Sun, Y. Yuan, M. Yao, H. Wang, D. Wang,
M. Gao, Y.-H. Chen and A. Lei, Org. Lett., 2019, 21, 1297–
300; (d) A. G. Meirinho, V. F. Pereira, G. M. Martins, S. Saba,
J. Rafique, A. L. Braga and S. R. Mendes, Eur. J. Org. Chem.,
019, 6465-6469; (e) F. Penteado, T. J. Peglow, M. S. Silva, G.
Biomol. Chem., 2019, 17, 6432–6440.
2
1
2
Notes and references
2
4
| J. Name., 2012, 00, 1-3
This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins